本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Pyxis Oncology, Inc.

1.17
-0.0200-1.68%
盤後1.180.0099+0.85%19:55 EDT
成交量:21.42萬
成交額:25.40萬
市值:7,247.88萬
市盈率:-0.75
高:1.22
開:1.22
低:1.16
收:1.19
資料載入中...
2023/05/11

重要事件披露

8-K - Current report
2023/05/11

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2023/05/10

[修訂]年度報告

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/04/04

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2023/03/28

重要事件披露

8-K - Current report
2023/03/23

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/03/22

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2023/03/22

重要事件披露

8-K - Current report
2023/03/22

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/03/16

重要事件披露

8-K - Current report
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/13

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/08

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/12/01

重要事件披露

8-K - Current report
2022/11/10

SEC問詢函

CORRESP [Cover] - Correspondence
2022/11/04

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/11/01

重要事件披露

8-K - Current report